Breast cancer represents 22 % of all cancer cases amongst the female population in Norway, which makes it by far the most common form of cancer in this group. It is a heterogeneous disease, and to guide use of adjuvant treatment, breast cancer patients are categorized into different subgroups based on biomarkers, which in turn enables specific target treatment options. Long non-coding RNAs (lncRNA) ...